scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10875-005-4083-5 |
P698 | PubMed publication ID | 15981091 |
P2093 | author name string | Sudhir Gupta | |
Wenzhong Guo | |||
Yiping Zhang | |||
Martin A Smith | |||
Raymond A Sobel | |||
Wallace W Tourtellotte | |||
Michael Olek | |||
Reng-Rong Da | |||
Stanley Van Den Noort | |||
Yufen Qin | |||
Lutz G Hilgenberg | |||
Richard T Robertson | |||
Hui-Min Ren | |||
Rashed Nagra | |||
P2860 | cites work | Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase | Q26778389 |
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease | Q28207482 | ||
Multiple sclerosis | Q28214785 | ||
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination | Q29614990 | ||
Novel selection method for engineered antibodies using the mechanism of Fv fragment stabilization in the presence of antigen. | Q32085155 | ||
Restricted use of VH4 germline segments in an acute multiple sclerosis brain | Q32107477 | ||
Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor | Q33204380 | ||
In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. II. A common clonal origin for periarteriolar lymphoid sheath-associated foci and germinal centers | Q36231790 | ||
Germinal centres in T-cell-dependent antibody responses | Q36774105 | ||
Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. | Q37385073 | ||
Antigen-driven selection of virgin and memory B cells | Q38595897 | ||
Immunoglobulin-containing cells in multiple-sclerosis plaques | Q39450637 | ||
On cerebrospinal fluid immunoglobulin-G (IgG) quotients in multiple sclerosis and other diseases. A review and a new formula to estimate the amount of IgG synthesized per day by the central nervous system | Q39989150 | ||
Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values | Q40833195 | ||
Rheumatoid factor specificity of a VH3-encoded antibody is dependent on the heavy chain CDR3 region and is independent of protein A binding | Q41011490 | ||
B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions | Q41697260 | ||
Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients | Q42619341 | ||
Changes in axonal physiology and morphology after chronic compressive injury of the rat thoracic spinal cord | Q43581094 | ||
Immunocytochemical study of Myelin-associated Glycoprotein (MAG) and Basic Protein (BP) in acute Experimental Allergic Encephalomyelitis (EAE) | Q46207713 | ||
Intrathecal B-cell clonal expansion, an early sign of humoral immunity, in the cerebrospinal fluid of patients with clinically isolated syndrome suggestive of multiple sclerosis | Q46266579 | ||
Autoantigen microarrays for multiplex characterization of autoantibody responses | Q46316594 | ||
Comparative analysis of the CD19+ and CD138+ cell antibody repertoires in the cerebrospinal fluid of patients with multiple sclerosis | Q47309556 | ||
Axonal pathology in multiple sclerosis. A historical note | Q48093198 | ||
Analysis of somatic mutation and class switching in naive and memory B cells generating adoptive primary and secondary responses | Q48348065 | ||
Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States | Q48384471 | ||
A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. | Q49029597 | ||
Ultrastructural studies of multiple sclerosis | Q49032921 | ||
B-cell memory is short-lived in the absence of antigen. | Q52120670 | ||
Activation of memory and virgin B cell clones in hyperimmune animals. | Q52129981 | ||
Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability. | Q52920250 | ||
Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. | Q54759503 | ||
Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein | Q59053168 | ||
Evolutionary nucleotide replacements in DNA | Q59075574 | ||
Correlation of magnetic resonance imaging parameters with clinical disability in multiple sclerosis: a preliminary study | Q62601716 | ||
Induction of hyperacute brain inflammation and demyelination by activated encephalitogenic T cells and a monoclonal antibody specific for a myelin/oligodendrocyte glycoprotein | Q69171682 | ||
Improved enzyme immunoassays using biotin-avidin-enzyme complex | Q70280102 | ||
Amino acid sequence based PCR primers for amplification of rearranged human heavy and light chain immunoglobulin variable region genes | Q72592702 | ||
Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients | Q73521619 | ||
Minimal structural elements of an inhibitory anti-ATF1/CREB single-chain antibody fragment (scFv41.4) | Q73585954 | ||
Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis | Q77563064 | ||
P433 | issue | 3 | |
P921 | main subject | multiple sclerosis | Q8277 |
cerebrospinal fluid | Q54196 | ||
P304 | page(s) | 254-264 | |
P577 | publication date | 2005-05-01 | |
P1433 | published in | Journal of Clinical Immunology | Q6294961 |
P1476 | title | Axon reactive B cells clonally expanded in the cerebrospinal fluid of patients with multiple sclerosis | |
P478 | volume | 25 |
Q37818921 | A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis |
Q57655341 | Advances in the molecular imaging of multiple sclerosis |
Q92538007 | Anti-Myelin Proteolipid Protein Peptide Monoclonal Antibodies Recognize Cell Surface Proteins on Developing Neurons and Inhibit Their Differentiation |
Q38030235 | Antibody-antigen pair probed by combinatorial approach and rational design: bringing together structural insights, directed evolution, and novel functionality |
Q37400354 | B cell characterization and reactivity analysis in multiple sclerosis |
Q37429555 | B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity |
Q38018052 | B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms |
Q37973165 | Changes at the nodal and perinodal axonal domains: a basis for multiple sclerosis pathology? |
Q35285839 | Chaperoned amyloid proteins for immune manipulation: α-Synuclein/Hsp70 shifts immunity toward a modulatory phenotype |
Q37376574 | Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis |
Q28282500 | Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies |
Q38198016 | Does disease-irrelevant intrathecal synthesis in multiple sclerosis make sense in the light of tertiary lymphoid organs? |
Q28078211 | Heterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and Repair |
Q36695714 | Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis |
Q36946331 | Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis? |
Q38020957 | Pathogenic and physiological autoantibodies in the central nervous system |
Q33777821 | Peptide reactivity between multiple sclerosis (MS) CSF IgG and recombinant antibodies generated from clonally expanded plasma cells in MS CSF. |
Q34595607 | Perturbed glucose metabolism: insights into multiple sclerosis pathogenesis |
Q39429415 | Phagocytosis of neuronal debris by microglia is associated with neuronal damage in multiple sclerosis |
Q90401279 | The Involvement and Therapy Target of Immune Cells After Ischemic Stroke |
Q36492380 | Toward biomarkers in multiple sclerosis: new advances. |